Replacement of aortic root and ascending aorta in adult congenital heart disease

Expert Review of Cardiovascular Therapy

Volumn 5, Issue 6, 2007, Pages 1087-1094

  Alghamdi, Abdullah A ^a   Van Arsdell, Glen S ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Adult congenital; Aortic root; Ascending aorta; Congenital

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; PROPRANOLOL;

AORTA ANEURYSM; AORTA DISEASE; AORTA DISSECTION; AORTA GRAFT; AORTA RECONSTRUCTION; AORTA ROOT; AORTA RUPTURE; AORTA SURGERY; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ASCENDING AORTA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; ECHOCARDIOGRAPHY; FALLOT TETRALOGY; HEART SURGERY; HUMAN; MARFAN SYNDROME; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PULMONARY VALVE ATRESIA; REVIEW; SURGICAL TECHNIQUE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGE FACTORS; ANGIOPLASTY, BALLOON; AORTA; AORTA, THORACIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIAC SURGICAL PROCEDURES; FEMALE; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFANT, NEWBORN; MALE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 37349121410     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.5.6.1087     Document Type: Review

References (82)

1. Moore KL, Persaud TVN. The Cardiovascular System. In: The Developing Human, Clinically Oriented Embryology (7th Edition). Moore KL, Persaud TVN (Eds). Saunders, PA, USA 239-380 (2003).
2. Kirby ML, Gale TF, Stewart DE. Neural crest cells contribute to normal aorticopulmonary septation. Science 220(4601), 1059-1061 (1983).
3. Kirby ML, Kumiski DH, Myers T, Cerjan C, Mishima N. Backtransplantation of chick cardiac neural crest cells cultured in LIF rescues heart development. Dev. Dyn. 198(4), 296-311 (1993).
4. Lo PC, Frasch M. Establishing A-P polarity in the embryonic heart tube: a conserved function of Hox genes in Drosophila and vertebrates? Trends Cardiovasc. Med. 13(5), 182-187 (2003).
5. Plageman TF Jr, Yutzey KE. T-box genes and heart development: putting the 'T' in heart. Dev. Dyn. 232(1), 11-20 (2005).
6. Boudjemline Y, Fermont L, Le BJ, Lyonnet S, Sidi D, Bonnet D. Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: a 6-year prospective study. J. Pediatrics 138(4), 520-524 (2001).
7. Burn J, Takao A, Wilson D et al. Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. J. Med. Gen. 30(10), 822-824 (1993).
8. Goldmuntz E, Clark BJ, Mitchell LE et al. Frequency of 22q11 deletions in patients with conotruncal defects. J. Am. Coll. Cardiol. 32(2), 492-498 (1998).
9. Maeda J, Yamagishi H, Matsuoka R et al. Frequent association of 22q11.2 deletion with tetralogy of Fallot. Am. J. Med. Gen. 92(4), 269-272 (2000).
10. Momma K, Takao A, Matsuoka R et al. Tetralogy of Fallot associated with chromosome 22q11.2 deletion in adolescents and young adults. Gen. Med. 3(1), 56-60 (2001).
11. Fallot A. Contribution to the pathological anatomy of blue disease (cardiac cyanosis). Mars. Med. 100, 779-797 (1963).
12. Park MK, Troxler RG. Cyanotic congenital Heart Defects. In: Pediatric cardiology for practitioners (4th Edition). Park MK, Troxler RG (Eds). Mosby MO, USA 174-240 (2002).
13. Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME, Kirklin JW. Life expectancy without surgery in tetralogy of Fallot. Am. J. Caidiol. 42(3), 458-466 (1978).
14. Glancy DL, Morrow AG, Roberts W. Malformations of the aortic valve in patients with the tetralogy of Fallot. Am. Heart J. 76(6), 755-759 (1968).
15. Marelli AJ, Perloff JK, Child JS, Laks H. Pulmonary atresia with ventricular septal defect in adults. Circulation 89(1), 243-251 (1994).
16. Matsuda H, Ihara K, Mori T, Kitamura S, Kawashima Y. Tetralogy of Fallot associated with aortic insufficiency. Ann. Thorac. Surg. 29(6), 529-533 (1980).
17. Dodds GA 3rd, Warnes CA, Danielson GK. Aortic valve replacement after repair of pulmonary atresia and ventricular septal defect or tetralogy of Fallot. J. Thorac. Cardiovasc. Surg. 113(4), 736-741 (1997).
18. Kim WH, Seo JW, Kim SJ, Song J, Lee J, Na CY. Aortic dissection late after repair of tetralogy of Fallot. Int. J. Cardiol. 101(3), 515-516 (2005).
19. Niwa K, Siu SC, Webb GD, Gatzoulis MA. Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot. Circulation 106(11), 1374-1378 (2002).
20. Rathi VK, Doyle M, Williams RB, Yamrozik J, Shannon RP, Biederman RW. Massive aortic aneurysm and dissection in repaired tetralogy of Fallot; diagnosis by cardiovascular magnetic resonance imaging. Int. J. Cardiol. 101(1), 169-170 (2005).
21. Bull K, Somerville J, Ty E, Spiegelhalter D. Presentation and attrition in complex pulmonary atresia. J. Am. Coll. Cardiol. 25(2), 491-499 (1995).
22. Karamlou T, McCrindle BW, Williams WG. Surgery insight: late complications following repair of tetralogy of Fallot and related surgical strategies for management. Nat. Clin. Prac. Cardiovasc. Med. 3(11), 611-622 (2006).
23. Tan JL, Gatzoulis MA, Ho SY. Aortic root disease in tetralogy of Fallot. Curr. Opin. Cardiol. 21(6), 569-572 (2006).
24. Ishizaka T, Ichikawa H, Sawa Y et al. Prevalence and optimal management strategy for aortic regurgitation in tetralogy of Fallot. Eur. J. Cardiothorac. Surg. 26(6), 1080-1086 (2004).
25. Niwa K, Perloff JK, Bhuta SM et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 103(3), 393-400 (2001).
26. Tan JL, Davlouros PA, McCarthy KP, Gatzoulis MA, Ho SY. Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: evidence of causative mechanism for aortic dilatation and aortopathy. Circulation 112(7), 961-968 (2005).
27. Therrien J, Warnes C, Daliento L et al. Canadian cardiovascular society consensus conference 2001 update: recommendations for the management of adults with congenital heart disease - Part III. Can. J. Cardiol. 17(11), 1135-1158 (2001).
28. Therrien J, Gatzoulis M, Graham T et al. Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease-Part II. Can J. Cardiol. 17(10), 1029-1050 (2001).
29. Basso C, Boschello M, Perrone C et al. An echocardiographic survey of primary school children for bicuspid aortic valve. Am. J. Cardiol. 93(5), 661-663 (2004).
30. Edwards JE. The congenital bicuspid aortic valve. Circulation 23, 485-488 (1961).
31. Nistri S, Basso C, Marzari C, Mormino P, Thiene G. Frequency of bicuspid aortic valve in young male conscripts by echocardiogram. Am. J. Cardiol. 96(5), 718-721 (2005).
32. Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am. J. Cardiol. 26(1), 72-83 (1970).
33. David TE. Surgery of the aortic root and ascending aorta. In: Surgery of the chest (7th Edition). Sellke FW, del Nodo PJ, Swanson SJ (Eds). Elsevier Saunders, PA, USA 1115-1135 (2005).
34. Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE, Sutton MG. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation 102(19 Suppl. 3), S9 (2000).
35. Nistri S, Sorbo MD, Marin M, Palisi M, Scognamiglio R, Thiene G. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 82(1), 19-22 (1999).
36. Hahn RT, Roman MJ, Mogtader AH, Devereux RB. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J. Am. Coll. Cardiol. 19(2), 283-288 (1992).
37. Ikonomidis JS, Jones JA, Barbour JR et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J. Thorac. Cardiovasc. Surg. 133(4), 1028-1036 (2007).
38. Aicher D, Urbich C, Zeiher A, Dimmeler S, Schafers HJ. Endothelial nitric oxide synthase in bicuspid aortic valve disease. Ann. Thorac. Surg. 83(4), 1290-1294 (2007).
39. Bauer M, Pasic M, Meyer R et al. Morphometric analysis of aortic media in patients with bicuspid and tricuspid aortic valve. Ann. Thorac. Surg. 74(1), 58-62 (2002).
40. de Sa M, Moshkovitz Y, Butany J, David TE. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the ross procedure. J. Thorac. Cardiovasc. Surg. 118(4), 588-594 (1999).
41. Huntington K, Hunter AG, Chan KL. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J. Am. Coll. Cardiol. 30(7), 1809-1812 (1997).
42. Clementi M, Notari L, Borghi A, Tenconi R. Familial congenital bicuspid aortic valve: a disorder of uncertain inheritance. Am. J. Med. Gen. 62(4), 336-338 (1996).
43. Davies RR, Kaple RK, Mandapati D et al. Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve. Ann. Thorac. Surg. 83(4), 1338-1344 (2007).
44. Bonow RO, Carabello B, de Leon AC et al. ACC/AHA Guidelines for the management of patients with valvular heart disease. executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on management of patients with valvular heart disease). J. Heart Valve Dis. 7(6), 672-707 (1998).
45. Cecconi M, Nistri S, Quarti A et al. Aortic dilatation in patients with bicuspid aortic valve. J. Cardiovasc. Med. 7(1), 11-20 (2006).
46. Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW. Bicuspid aortic valve is heritable. J. Am. Coll. Cardiol. 44(1), 138-143 (2004).
47. Pyeritz RE. Genetics and cardiovascular disease. In: Braunwalds's Heart Disease: A Textbook of Cardiovascular Medicine (7th Edition). Zipes DP, Libby P, Bonow RO et al. (Eds). Elsevier Saunders, PA, USA 1867-909 (2005).
48. Sakai LY, Keene DR, Glanville RW, Bachinger HP. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. J. Biol. Chem. 266(22), 14763-14770 (1991).
49. Reinhardt DP, Keene DR, Corson GM et al. Fibrillin-1: organization in microfibrils and structural properties. J. Mol. Biol. 258(1), 104-116 (1996).
50. Zhang H, Hu W, Ramirez F. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J. Cell Biol. 129(4), 1165-1176 (1995).
51. Hayward C, Porteous ME, Brock DJ. Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: report of 12 novel mutations. Hum. Mutat. 10(4), 280-289 (1997).
52. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am. J. Med. Gen. 62(4), 417-426 (1996).
53. Judge DP, Dietz HC. Marfan's syndrome. Lancet 366(9501), 1965-1976 (2005).
54. Adams JN, Trent RJ. Aortic complications of Marfan's syndrome. Lancet 352(9142), 1722-1723 (1998).
55. Silverman DI, Burton KJ, Gray J et al. Life expectancy in the Marfan syndrome. Am. J. Cardiol. 75(2), 157-160 (1995).
56. Murdoch JL, Walker BA, Halpern BL, Kuzma JW, McKusick VA. Life expectancy and causes of death in the Marfan syndrome. N. Engl. J. Med. 286(15), 804-808 (1972).
57. Bruno L, Tredici S, Mangiavacchi M, Colombo V, Mazzotta GF, Sirtori CR. Cardiac, skeletal, and ocular abnormalities in patients with Marfan's syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br. Heart J. 51(2), 220-230 (1984).
58. Januzzi JL, Isselbacher EM, Fattori R et al. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J. Am. Coll. Cardiol. 43(4), 665-669 (2004).
59. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term β-adrenergic blockade in Marfan's syndrome. N. Engl. J. Med. 330(19), 1335-1341 (1994).
60. Groenink M, de Roos A, Mulder BJ, Spaan JA, van der Wall EE. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following β-blocker therapy in the Marfan syndrome. Am. J. Cardiol. 82(2), 203-208 (1998).
61. Rios AS, Silber EN, Bavishi N et al. Effect of long-term β-blockade on aortic root compliance in patients with Marfan syndrome. Am. Heart J. 137(6), 1057-1061 (1999).
62. Rossi-Foulkes R, Roman MJ, Rosen SE et al. Phenotypic features and impact of β blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. Am. J. Cardiol. 83(9), 1364-1368 (1999).
63. Yetman AT. Cardiovascular pharmacotherapy in patients with Marfan syndrome. Am. J. Cardiovasc. Drugs 7(2), 117-126 (2007).
64. Yacoub MH, Sundt TM, Rasmi N. Management of aortic valve incompetence in patients with Marfan syndrome. In: Cardiovascular Aspects of Marfan Syndrome. Hetzer R, Gehle P, Ennker J (Eds). Steinkopff, Darmstadt, Germany 71-81 (1995).
65. Yacoub MH. Valve-conserving operation for aortic root aneurysm or dissection. In: Operative Techniques in Cardiac and Thoracic Surgery: A Comparative Atlas. Cox JL, Sundt TM (Eds). WB Saunders, PA, USA 57-67 (1996).
66. Yacoub MH, Gehle P, Chandrasekaran V, Birks EJ, Child A, Radley-Smith R. Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root. J. Thorac. Cardiovasc. Surg. 115(5), 1080-1090 (1998).
67. David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J. Thorac. Cardiovasc. Surg. 103(4), 617-621 (1992).
68. Cochran RP, Kunzelman KS, Eddy AC, Hofer BO, Verrier ED. Modified conduit preparation creates a pseudosinus in an aortic valve-sparing procedure for aneurysm of the ascending aorta. J. Thorac. Cardiovasc. Surg. 109(6), 1049-1057 (1957).
69. Bentall H, De Bono A. A technique for complete replacement of the ascending aorta. Thorax 23(4), 338-339 (1968).
70. Kiziltan HT, Topcu S, Ozbarlas N, Kayaselcuk F. Combined primary repair of tetralogy of Fallot and aortic root replacement. Ann. Thorac. Surg. 72(6), 2124-2125 (2001).
71. Gott VL, Cameron DE, Alejo DE et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann. Thorac. Surg. 73(2), 438-443 (2002).
72. Gott VL, Greene PS, Alejo DE et al. Replacement of the aortic root in patients with Marfan's syndrome. N. Engl. J. Med. 340(17), 1307-1313 (1999).
73. Finkbohner R, Johnston D, Crawford ES, Coselli J, Milewicz DM. Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation 91(3), 728-733 (1995).
74. Silverman DI, Burton KJ, Gray J et al. Life expectancy in the Marfan syndrome. Am. J. Cardiol. 75(2), 157-160 (1995).
75. Kouchoukos NT, Wareing TH, Murphy SF, Perrillo JB. Sixteen-year experience with aortic root replacement. Results of 172 operations. Ann. Surg. 214(3), 308-318 (1991).
76. Birks EJ, Webb C, Child A, Radley-Smith R, Yacoub MH. Early and long-term results of a valve-sparing operation for Marfan syndrome. Circulation 100(19 Suppl.), S35 (1999).
77. David TE, Feindel CM, Webb GD, Colman JM, Armstrong S, Maganti M. Long-term results of aortic valve-sparing operations for aortic root aneurysm. J. Thorac. Cardiovasc. Surg. 132(2), 347-354 (2006).
78. David TE, Armstrong S, Ivanov J, Feindel CM, Omran A, Webb G. Results of aortic valve-sparing operations. J. Thorac. Cardiovasc. Surg. 122(1), 39-46 (2001).
79. de Oliveira NC, David TE, Ivanov J et al. Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J. Thorac. Cardrovasc. Surg. 125(4), 789-796 (2003).
80. David TE. Current practice in Marfan's aortic root surgery: reconstruction with aortic valve preservation or replacement? What to do with the mitral valve? J. Cardiac Surg. 12(Suppl. 2), S50 (1997).
81. David TE, Feindel CM, Bos J. Repair of the aortic valve in patients with aortic insufficiency and aortic root aneurysm. J. Thorac. Cardiovasc. Surg. 109(2), 345-351 (1995).
82. Anttila V, Piaszczynski M, Mora B et al. Improved outcome with composite graft versus homograft root replacement for children with aortic root aneurysms. Eur. J. Cardiothorac. Surg. 27(3), 420-424 (2005).